Hotouras A, Ribas Y, Zakeri S A, Nunes Q M, Murphy J, Bhan C, Wexner S D
National Centre for Bowel Research and Surgical Innovation, London, UK.
Department of Surgery, Whittington Hospital NHS Trust, London, UK.
Colorectal Dis. 2016 Oct;18(10):O337-O366. doi: 10.1111/codi.13406.
The relationship between obesity, body mass index (BMI) and laparoscopic colorectal resection is unclear. Our object was to assess systematically the available evidence to establish the influence of obesity and BMI on the outcome of laparoscopic colorectal resection.
A search of PubMed/Medline databases was performed in May 2015 to identify all studies investigating the impact of BMI and obesity on elective laparoscopic colorectal resection performed for benign or malignant bowel disease. Clinical end-points examined included operation time, conversion rate to open surgery, postoperative complications including anastomotic leakage, length of hospital stay, readmission rate, reoperation rate and mortality. For patients who underwent an operation for cancer, the harvested number of lymph nodes and long-term oncological data were also examined.
Forty-five studies were analysed, the majority of which were level IV with only four level III (Oxford Centre for Evidence-based Medicine 2011) case-controlled studies. Thirty comparative studies containing 23 649 patients including 17 895 non-obese and 5754 obese showed no significant differences between the two groups with respect to intra-operative blood loss, overall postoperative morbidity, anastomotic leakage, reoperation rate, mortality and the number of retrieved lymph nodes in patients operated on for malignancy. Most studies, including 15 non-comparative studies, reported a longer operation time in patients who underwent a laparoscopic procedure with the BMI being an independent predictor in multivariate analyses for the operation time.
Laparoscopic colorectal resection is safe and technically and oncologically feasible in obese patients. These results, however, may vary outside of high volume centres of expertise.
肥胖、体重指数(BMI)与腹腔镜结直肠切除术之间的关系尚不清楚。我们的目的是系统评估现有证据,以确定肥胖和BMI对腹腔镜结直肠切除术结局的影响。
2015年5月检索了PubMed/Medline数据库,以识别所有研究BMI和肥胖对因良性或恶性肠道疾病而进行的择期腹腔镜结直肠切除术影响的研究。所检查的临床终点包括手术时间、转为开放手术的比例、术后并发症(包括吻合口漏)、住院时间、再入院率、再次手术率和死亡率。对于接受癌症手术的患者,还检查了采集的淋巴结数量和长期肿瘤学数据。
分析了45项研究,其中大多数为IV级研究,只有四项III级(牛津循证医学中心,2011年)病例对照研究。30项比较研究纳入了23649例患者,其中非肥胖患者17895例和肥胖患者5754例,两组在术中失血、总体术后发病率、吻合口漏、再次手术率、死亡率以及恶性肿瘤手术患者的淋巴结回收数量方面无显著差异。大多数研究(包括15项非比较研究)报告称,接受腹腔镜手术患者的手术时间更长,BMI在手术时间的多变量分析中是一个独立预测因素。
腹腔镜结直肠切除术在肥胖患者中是安全的,在技术和肿瘤学方面是可行的。然而,这些结果在高容量专业中心之外可能会有所不同。